Loop Dx

Revolutionizing sepsis detection for early intervention.

#Life_Sciences

Point Circle Elephant

Loop Dx

Loop have developed a new first-class in vitro cellular immuno assay that detects sepsis within the first hour of bloodstream infection. A patented method and kit identify immune activity biomarkers with a sensitivity 3 times greater than the leading competitor, PCT. Additionally, our diagnostic process is 10 times faster than pathogen identification. 

The Elephants
Involved

Our Role

  • Public Funding
Raised
0 M

Loop Dx and
Inveniam

Inveniam supported to achieve the SoE from the EIC Accelerator and winning the CDTi Public Funding.

Ready to Take Control of Your Innovation?

We look forward to learning about your innovation.